Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)

Vaccination Refusal Clinical Trial

Official title:

Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05225064
• Other study ID #: 2000031541
• Status: Completed
• Phase: N/A
• Start date: January 19, 2022
• Est. completion date: April 27, 2022

Study information

• Verified date: June 2022
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Working with governments in Bihar, India, we will evaluate a number of mechanisms to increase vaccine uptake. These include household vaccination visits instead of community vaccination clinic.monetary and non-monetary incentives, and concurrent mask promotion. This ClinicalTrials entry contains results only for the study in Bihar.

Description:

The goal of the study is to identify strategies that best promote and support COVID vaccine uptake in developing countries, we propose to test a range of scalable social and behavioural interventions. This could help policy makers design and employ interventions that are effective. This is especially valuable in resource constrained contexts where funds and institutional resources can be diverted towards interventions that have proven to work. In Bihar the intervention will be village-level social mobilization involving community promotion, including in-person vaccine reinforcement, and household-level social mobilization. Some treatment villages will receive household- level interventions with varying intensity (different proportion of households will be visited). There will also an accompanying mask distribution campaign during household visits where the importance of mask-wearing as a complement to vaccine use will be explained. This ClinicalTrials entry contains results only for the study in Bihar.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 114512
• Est. completion date: April 27, 2022
• Est. primary completion date: April 27, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• Lives in study village

Exclusion Criteria:

• Does not live in study village

Related Conditions & MeSH terms

• COVID-19
• Vaccination Refusal

Intervention

Behavioral:
• Incentives to be vaccinated
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated

Device:
• Mask
Individuals are given cloth masks

Behavioral:
• Encouragement to wear a mask
Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask
• Vaccination made more convenient
Vaccines are conducted at the household-level rather than the village-level
• Social mobilization campaign to be vaccinated
Village-level social mobilization campaign to be vaccinated

Locations

Country	Name	City	State
India	Project Concern International	Patna	Bihar

Sponsors (5)

Lead Sponsor	Collaborator
Yale University	Innovations for Poverty Action, Lahore University of Management Sciences, University of California, Berkeley, University of Connecticut

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percent of individuals who receive the first, second, or third dose of covid vaccine	Prevalence of vaccination with difference doses	up to 4 weeks (endline may vary depending on estimated uptake rates)